1001 - 1025 of 6568 Results
Title
Year
-
OPENTitle: Abnormal Topological Network in Parkinson’s Disease With Impulse Control Disorders: A Resting-State Functional Magnetic Resonance Imaging StudyJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 651710End Page: 651710Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.651710Best OA location URL: https://doi.org/10.3389/fnins.2021.651710Citation Count: 3
-
OPENTitle: Development and Application of High-Throughput Single Cell Lipid Profiling: A Study of SNCA-A53T Human Dopamine NeuronsJournal Name: iSciencePublisher: Elsevier BVVol: 23Issue #: 11Start Page: 101703End Page: 101703Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2020.101703Best OA location URL: https://doi.org/10.1016/j.isci.2020.101703Citation Count: 21
-
OPENTitle: Constipation and sleep behaviour disorder associate with processing speed and attention in males with Parkinson’s disease over five years follow-upJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 19014End Page: 19014Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-75800-4Best OA location URL: https://www.nature.com/articles/s41598-020-75800-4.pdfCitation Count: 26
-
OPENTitle: Investigation of Somatic Mutations in Human Brains Targeting Genes Associated With Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 570424End Page: 570424Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.570424Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.570424/pdfCitation Count: 10
-
OPENTitle: Exosome markers of LRRK2 kinase inhibitionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page: 32End Page: 32Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00138-7Best OA location URL: https://www.nature.com/articles/s41531-020-00138-7.pdfCitation Count: 24
-
OPENTitle: Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page: 34End Page: 34Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00134-xBest OA location URL: https://www.nature.com/articles/s41531-020-00134-x.pdfCitation Count: 55
-
OPENTitle: What does heritability of Alzheimer’s disease represent?Journal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 4Start Page: e0281440End Page: e0281440Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0281440Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0281440&type=printableCitation Count: 45
-
OPENTitle: Episodic memory deficit in HIV infection: common phenotype with Parkinson’s disease, different neural substratesJournal Name: Brain Structure and FunctionPublisher: Springer Science and Business Media LLCVol: 228Issue #: 3-4Start Page: 845End Page: 858Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00429-023-02626-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00429-023-02626-x.pdfCitation Count: 4
-
OPENTitle: Local genetic correlations exist among neurodegenerative and neuropsychiatric diseasesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 70End Page: 70Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00504-1Best OA location URL: https://www.nature.com/articles/s41531-023-00504-1.pdfCitation Count: 22
-
OPENTitle: Explainable classification of Parkinson’s disease using deep learning trained on a large multi-center database of T1-weighted MRI datasetsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 38Issue #:Start Page: 103405End Page: 103405Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2023.103405Best OA location URL: https://doi.org/10.1016/j.nicl.2023.103405Citation Count: 74
-
OPENTitle: Novel VARS1 variants define new clinical and molecular subtypes of a rare neurodevelopmental syndromeJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePublisher: Elsevier BVVol: 1872Issue #: 4Start Page: 168184End Page: 168184Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.bbadis.2026.168184Best OA location URL: https://doi.org/10.1016/j.bbadis.2026.168184Citation Count: 0
-
OPENTitle: The effect of cardiovascular risk on disease progression in de novo Parkinson's disease patients: An observational analysisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 14Issue #:Start Page: 1138546End Page: 1138546Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2023.1138546Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2023.1138546/pdfCitation Count: 2
-
OPENTitle: Targeted Extracellular Vesicle Gene Therapy for Modulating Alpha-Synuclein Expression in Gut and Spinal CordJournal Name: PharmaceuticsPublisher: MDPI AGVol: 15Issue #: 4Start Page: 1230End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/pharmaceutics15041230Best OA location URL: https://www.mdpi.com/1999-4923/15/4/1230/pdf?version=1681369684Citation Count: 12
-
OPENTitle: echolocatoR : an automated end-to-end statistical and functional genomic fine-mapping pipelineJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 38Issue #: 2Start Page: 536End Page: 539Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/bioinformatics/btab658Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10060715/pdf/btab658.pdfCitation Count: 36
-
OPENTitle: Abnormal dynamic functional connectivity changes correlated with non-motor symptoms of Parkinson’s diseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page: 1116111End Page: 1116111Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2023.1116111Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2023.1116111/pdfCitation Count: 11
-
OPENTitle: Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical PracticeJournal Name: Parkinson's DiseasePublisher: WileyVol: 2021Issue #:Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2021/2603641Best OA location URL: https://downloads.hindawi.com/journals/pd/2021/2603641.pdfCitation Count: 12
-
OPENTitle: Validation of human microRNA target pathways enables evaluation of target prediction toolsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 49Issue #: 1Start Page: 127End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkaa1161Best OA location URL: https://academic.oup.com/nar/article-pdf/49/1/127/35597117/gkaa1161.pdfCitation Count: 70
-
OPENTitle: Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule countingJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 5217End Page: 5217Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-32480-0Best OA location URL: https://www.nature.com/articles/s41598-023-32480-0.pdfCitation Count: 39
-
OPENTitle: Parkinson’s disease population-wide registries in the United States: Current and future opportunitiesJournal Name: Frontiers in Digital HealthPublisher: Frontiers Media SAVol: 5Issue #:Start Page: 1149154End Page: 1149154Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fdgth.2023.1149154Best OA location URL: https://www.frontiersin.org/articles/10.3389/fdgth.2023.1149154/pdfCitation Count: 9
-
OPENTitle: Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activitiesJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 184Issue #:Start Page: 106409End Page: 106409Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2022.106409Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10074477/pdf/nihms-1882815.pdfCitation Count: 16
-
OPENTitle: Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicityJournal Name: Brain PathologyPublisher: WileyVol: 33Issue #: 2Start Page: e13130End Page: e13130Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/bpa.13130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bpa.13130Citation Count: 4
- B lymphocyte responses in Parkinson’s disease and their possible significance in disease progression2023OPENTitle: B lymphocyte responses in Parkinson’s disease and their possible significance in disease progressionJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 5Issue #: 2Start Page: fcad060End Page: fcad060Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcad060Best OA location URL: https://academic.oup.com/braincomms/article-pdf/5/2/fcad060/49650847/fcad060.pdfCitation Count: 42
-
OPENTitle: Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease ModelsJournal Name: AntioxidantsPublisher: MDPI AGVol: 12Issue #: 3Start Page: 582End Page: 582Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/antiox12030582Best OA location URL: https://www.mdpi.com/2076-3921/12/3/582/pdf?version=1677573522Citation Count: 14
-
OPENTitle: Structural connectivity and brain network analyses in Parkinson's disease: A cross-sectional and longitudinal studyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 14Issue #:Start Page: 1137780End Page: 1137780Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2023.1137780Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2023.1137780/pdfCitation Count: 22
-
OPENTitle: Starburst amacrine cells, involved in visual motion perception, lose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson’s disease patientsJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 17End Page: 17Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-023-00348-yBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-023-00348-yCitation Count: 13